Fetomaternal

 

08:30-10:00
FETAL MONITORING
Capsule
 Very few changes have been implemented in the last two decades in fetal monitoring and induction of labor
Chairpersons
Tak Yeung Leung, Hong Kong
Luming Sun, China
 08:30-09:00
Intrapartum fetal monitoring is a risky business for both fetus and doctor
Gerard H.A. Visser, Netherlands 
 09:00-09:30
Auscultation in labor is the recommended technique by ACOG, RCOG and SOGC, while 90% of patients are monitored electronically. Why?
Dan Farine, Canada 
 09:30-10:00
Monitoring of multiple pregnancies during delivery
Issac Blickstein, Israel
10:00-10:20 Coffee break

   

10:20-11:05
ADVANCED TECHNOLOGIES TO IMPROVE IVF OUTCOMES
Supported by Illumina
 
Robert C.Henke, USA

   

11:50-12:40
Lunch Break

   

12:40-14:10
PRENATAL DIAGNOSIS IN THE ERA OF NIPT
Capsule
 Since its initial introduction into the prenatal screening/testing spectrum of care, the field of non-invasive prenatal testing (NIPT) has evolved and expanded rapidly beyond the common aneuploidies and beyond the high risk pregnancy population
Chairpersons

Isaac Blickstein, Israel
Nan Okun, Canada
 12:40-13:10
NIPT: The scientific basics for your practice
Tak Yeung Leung, Hong Kong
 13:10-13:40

Clinical considerations for incorporating NIPT into your practice
Nan Okun, Canada
 13:40-14:10
Will NIPT replace CVS and amniocentesis? 
Tak Yeung Leung, Hong Kong
14:10-14:30
Poster viewing

   

14:30-16:00
PROGESTERONE SUPPORT DURING PREGNANCY
Chairpersons
Nan Okun, Canada
Walfrido W. Sumpaico, Philippines
 14:30-14:50
Guidelines on progesterone and what is new
Dan Farine, Canada 
 14:50-15:15
Progesterone treatment for PTL
Luming Sun, China
 15:15-16:00

Debate: 17 OHP vs. natural progesterone
17OHP: Tsz Kin Lo, Hong Kong
Natural progesterone:Isaac Blickstein, Israel
Discussion
16:00-16:30  Coffee break

  

16:30-18:00 

HOW TO MANAGE TWIN PREGNANCIES 

Chairpersons
Isaac Blickstein, Israel
Tak Yeung Leung, Hong Kong
 16:30-17:00
Why are MC twins a major anomaly?
Isaac Blickstein , Israel
 17:00-17:30
How to manage MC twin pregnancies
Tak Yeung Leung, Hong Kong
 17:30-18:00
Selective IUGR in twins
Luming Sun , China

   

08:30-10:00
INTRAPARTUM CARE
Capsule
The controversy over induction of labor and the association with increased CS is as old as the drug and as current as modern obstetrics. Why?
Chairpersons
Luming Sun, China
Tuangsit Wataganara, Thailand
 08:30-09:15
Debate: Oxytocin to accelerate or induce labor: Overused,
unnecessary and risky
Untrue: Aris Antsaklis, Greece
True: Michael Robson, Ireland 
Discussion
 09:15-09:40 Induction of labor to promote VBAC
Aris Antsaklis, Greece
 09:40-10:00 Deveolping pharmaceutical treatments for pre-eclampsia
Amy Winship, Australia
10:00-10:20 Coffee break

   

 
Workshop on CS rate
Sessions 7-9
Capsule
The very high rate of CS all around the world, China included, requires a thorough discussion of the controversial indications and how can we reduce the CS rate

   

10:20-11:50
INDUCTION OF LABOR AND CS
Chairpersons
Aris Antsaklis, Greece
Tsz Kin Lo, Hong Kong
 10:20-10:40

Women are designed to deliver vaginally and not by CS
Gerard H.A. Visser, Netherlands
 10:40-11:05
Classification of CS
Michael Robson, Ireland
 11:05-11:50
Debate: Induction of labor does not increase the CS rate 
True: Ben WJ Mol, Australia 
Not true: Michael Robson, Ireland  
Discussion
11:50-12:40 Lunch break

   

12:40-14:10
 CS IN BREECH PRESENTATION
Capsule
The art of breech delivery is disappearing in many centres, and breech presentation seems to be an obvious indication for CS. So why is the controversy on breech delivery still ongoing?
Chairpersons
 Dan Farine, Canada
Luming Sun, China
 12:40-13:25
Debate: Should all breeches be delivered by CS?
Pro: Michael Robson, Ireland
Not true: Gerard H.A. Visser, Netherlands
Discussion
 13:25-13:45
When and how to deliver MC twins
Isaac Blickstein, Israel
 13:45-14:10
 Dystocia: Poorly defined, poorly understood and poorly managed
 Michael Robson, Ireland  
14:10-14:30
Poster viewing

   

14:30-16:00
CS AND VBAC
Chairpersons
Tsz Kin Lo, Hong Kong
Michael Robson, Ireland
 14:30-15:30
Debate: There is no place for VBAC: Once a Caesarean, always a Caesarean  
True: Ben WJ Mol, Australia
Not true: Michael Robson, Ireland
Discussion
 15:30-16:00
How to reduce C-Section rates in China
Ruyan Pang, China
16:00-16:30
Coffee break

   

16:30-18:00
OBSTETRIC ISSUES IN ASIA
Organized by AOFOG
Chairperson Walfrido W. Sumpaico, Philippines
Tony Tan, Singapore
 16:30-17:00 Clinical strategies to reduce unexplained stillbirths
Tony Tan, Singapore
 17:00-17:30 Screening for pre-eclampsia: is it ready for routine clinical use?
Tuangsit Wataganara, Thailand
 17:30-18:00 Is the Friedman's curve obsolete?
Walfrido W. Sumpaico, Philippines

   

 08:30-10:00
PRE-GESTATIONAL WEIGHT AND WEIGHT GAIN DURING PREGNANCY: AN OLD DILEMMA REVISITED
Capsule
 Pre-gestational weight and weight gain during pregnancy are important determinants of pregnancy outcomes. Can we do better and improve outcomes? Can we avoid the increased risks?
Chairpersons Isaac Blickstein, Israel
Tony Tan, Singapore
 08:30-09:00
Gestational diabetes
Aris Antsaklis, Greece
 09:00-09:30
Is gestational diabetes a disease?
Gerard H.A. Visser, Netherlands
 09:30-10:00
Are the recommendations for weight gain during pregnancy realistic?
Isaac Blickstein, Israel
 10:00-10:20
Coffee break

     

10:20-11:50
HIGH RISK FOR LITIGATION
Capsule
Can better understanding decrease litigation?
Chairperson
Gerard H.A. Visser, Netherlands
 10:20-10:50
Are the criteria for the association between perinatal events and brain damage valid? 
Isaac Blickstein, Israel
 10:50-11:20
Already brain damaged upon admission: Can we diagnose?
Dan Farine, Canada
 11:20-11:50
 Shoulder dystocia and Erb’s palsy: Can we do better?
Isaac Blickstein, Israel